Neurology Today in 5  By  cover art

Neurology Today in 5

By: American Academy of Neurology
  • Summary

  • Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.
    2024
    Show more Show less
activate_primeday_promo_in_buybox_DT
Episodes
  • Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
    Jul 18 2024

    In this week’s podcast, Neurology Today’s editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

    Show more Show less
    5 mins
  • Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
    Jul 4 2024

    In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.

    Show more Show less
    5 mins
  • When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
    Jun 20 2024

    In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.

    This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

    Show more Show less
    5 mins

What listeners say about Neurology Today in 5

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.